LLY vs WST
By Alex · Tickerpine
Eli Lilly and Company vs West Pharmaceutical Services, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | WST |
|---|---|---|
| Price | $1,208.12 | $350.85 |
| Market cap | $1.08T | $24.79B |
| P/E ratio | 42.9 | 47.0 |
| ROE | 107.46% | 19.13% |
| Profit margin | 34.99% | 16.85% |
| Revenue growth | 55.50% | 21.00% |
| Dividend yield | 0.57% | 0.25% |
| Beta | 0.52 | 1.18 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs WST in plain English
- LLY is the bigger company — about 43.5× the market cap of WST.
- LLY is cheaper on earnings (P/E 42.9 vs 47.0).
- LLY earns a higher return on equity (107% vs 19%).
- LLY is growing revenue faster (56% vs 21%).
- LLY has the higher dividend yield (0.57% vs 0.25%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
WST return calculator
See what $1,000 in West Pharmaceutical Services, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.